JGP Global Gestao de Recursos’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,841
Closed -$272K 58
2020
Q4
$272K Sell
2,841
-71
-2% -$6.86K 1.02% 36
2020
Q3
$280K Sell
2,912
-135
-4% -$15.6K 0.15% 50
2020
Q2
$372K Hold
3,047
0.22% 36
2020
Q1
$264K Sell
3,047
-87
-3% -$8.51K 0.11% 50
2019
Q4
$337K Buy
3,134
+37
+1% +$3.87K 0.12% 49
2019
Q3
$279K Buy
3,097
+163
+6% +$15.2K 0.15% 52
2019
Q2
$248K Sell
2,934
-344
-10% -$28.2K 0.1% 45
2019
Q1
$289K Buy
3,278
+281
+9% +$23.5K 0.11% 45
2018
Q4
$214K Buy
+2,997
New +$287K 0.26% 44
2017
Q3
Sell
-5,890
Closed -$271K 31
2017
Q2
$271K Sell
5,890
-1,013
-15% -$49.1K 0.36% 14
2017
Q1
$299K Buy
6,903
+1,140
+20% +$48.8K 0.25% 16
2016
Q4
$223K Buy
+5,763
New +$261K 0.11% 40

Other funds holding NBIX

JGP Global Gestao de Recursos's NBIX Position: Q1 2021 in Review

JGP Global Gestao de Recursos sold out of Neurocrine Biosciences (NBIX) in Q1 2021, closing a stake of 2,841 shares — an estimated $272K sold.

JGP Global Gestao de Recursos first reported a position in NBIX in Q4 2016 and held it in 12 quarters. The position peaked at $372K in Q2 2020. 419 funds tracked by Wall St. Rank hold NBIX as of Q1 2021.

  • JGP Global Gestao de Recursos reported no remaining Neurocrine Biosciences position as of Q1 2021 after selling out during the quarter.
  • JGP Global Gestao de Recursos sold 2,841 Neurocrine Biosciences shares in Q1 2021, an estimated $272K.
  • JGP Global Gestao de Recursos first reported a position in Neurocrine Biosciences in Q4 2016 and held it in 12 quarters.
  • JGP Global Gestao de Recursos's Neurocrine Biosciences position peaked at $372K in Q2 2020.
  • 419 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2021.

Based on JGP Global Gestao de Recursos's 13F filing for Q1 2021, filed 11 May 2021.